Clinical trial

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

NCT00078247

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Abacavir Normalized identity: abacavirView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Lamivudine Normalized identity: lamivudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Zidovudine Normalized identity: zidovudineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Tuberculosis treatment Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE3

Conditions

HIV Infectionsunresolved

Tuberculosisverified · MONDO: tuberculosis

Interventions

AbacavirDRUG · verified · RxNorm: abacavir

LamivudineDRUG · verified · RxNorm: lamivudine

ZidovudineDRUG · verified · RxNorm: zidovudine

Tuberculosis treatmentDRUG

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Makerere Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00078247 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.